DCPS is a synthetic lethal therapeutic target in acute myeloid leukemia expressing low levels of FHIT https://www.nature.com/articles/s41375-025-02661-z

The role of ASXL1, SRSF2, and EZH2 mutations in chromatin dysregulation of myelodysplastic neoplasia and acute myeloid leukemia https://www.nature.com/articles/s41375-025-02657-9

Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes https://www.nature.com/articles/s41375-025-02648-w

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice https://www.nature.com/articles/s41375-025-02662-y

Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia https://www.nature.com/articles/s41375-025-02651-1